World's Best Scientists 2026 revealed!
The Lancet Haematology
H-index 67

The Lancet Haematology

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 116 474 334 67

Additional Metrics

Number of Best Scientists*: 573
Documents by Best Scientists*: 368
Top 100 Ranked Scientists*: 11
SCIMAGO H-index: 103
SCIMAGO SJR: 4.936
Impact Factor: 17.7

Overview

Top Research Topics at The Lancet Haematology?

The journal aims to foster the development of research in Internal medicine, Oncology, Intensive care medicine, Transplantation and Surgery. Internal medicine study tackled is connected to the field of Gastroenterology. Oncology research presented in the journal encompasses a variety of subjects, including Leukemia, Multiple myeloma and Lymphoma.

The work on Intensive care medicine addressed in The Lancet Haematology expands to the thematically related Disease. The research on Transplantation discussed in it draws on the closely related field of Retrospective cohort study. While the journal primarily focused on Retrospective cohort study, it also opened dialogues on the discipline of Hazard ratio.

Regimen is a focus of the Surgery works in The Lancet Haematology. The journal dives deep in exploring the relationship between the study of Adverse effect and Neutropenia. The study on Clinical trial presented in The Lancet Haematology intersects with the topics under Randomized controlled trial.

  • Internal medicine (46.79%)
  • Oncology (17.13%)
  • Intensive care medicine (11.88%)

What are the most cited papers published in the journal?

  • Coagulation abnormalities and thrombosis in patients with COVID-19. (637 citations)
  • Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. (377 citations)
  • Ionising radiation and risk of death from leukaemia and lymphoma in radiation-monitored workers (INWORKS): an international cohort study (252 citations)

Research areas of the most cited articles at The Lancet Haematology:

The most cited papers investigate studies in Internal medicine, Surgery, Transplantation, Adverse effect and Clinical endpoint. The most cited articles dive deep in exploring the relationship between the study of Internal medicine and Gastroenterology. The most cited articles focus on Transplantation but also tackle concerns of closely connected disciplines like

  • Retrospective cohort study which intersects with area such as Cohort study,
  • Pediatrics, which have a strong connection to Cohort..

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Cancer
  • Disease

The previous edition focused in particular on these issues:

The Lancet Haematology primarily focuses on research topics in Internal medicine, Transplantation, Intensive care medicine, Oncology and Disease. The journal connects the study in Internal medicine with the closely related area of Gastroenterology. The Gastroenterology works featured in it incorporate elements from Refractory and Lenalidomide, Dexamethasone.

It explores research in Cohort study and overlapping concepts in Retrospective cohort study to expand the discourse in Transplantation. The journal tackles research in various disciplines, including Oncology and Text mining. It holds forums on Disease that merges themes from other disciplines such as Cell and Pediatrics.

The most cited articles from the last journal are:

  • Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. (60 citations)
  • Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma. (35 citations)
  • Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial (24 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in The Lancet Haematology (based on the number of publications) are:

  • Hagop M. Kantarjian (22 papers) published 2 papers at the last edition, 1 less than at the previous edition,
  • Jorge E. Cortes (14 papers) published 1 paper at the last edition,
  • Farhad Ravandi (14 papers) published 1 paper at the last edition, 1 less than at the previous edition,
  • Guillermo Garcia-Manero (13 papers) published 1 paper at the last edition, 1 less than at the previous edition,
  • Elias Jabbour (13 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in The Lancet Haematology (based on the number of publications) are:

  • University of Texas MD Anderson Cancer Center (59 papers) published 12 papers at the last edition, 1 more than at the previous edition,
  • Harvard University (51 papers) published 10 papers at the last edition, 6 less than at the previous edition,
  • Mayo Clinic (42 papers) published 5 papers at the last edition, 4 less than at the previous edition,
  • Memorial Sloan Kettering Cancer Center (29 papers) published 9 papers at the last edition the same number as at the previous edition,
  • Fred Hutchinson Cancer Research Center (27 papers) published 4 papers at the last edition, 4 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 20.63% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 29.13% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.81% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 21.26% of all publications and 37.80% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Exploring LPN Programs in Connection with The Lancet Haematology Studies

Relating the academic and clinical studies presented in the Lancet Haematology with practical application trends in the medical field can provide valuable context to the potential impact of their research. A case in point is Licensed Practical Nurses (LPNs), who often deal with patients suffering from conditions highlighted in the Lancet Haematology such as Leukemia, Multiple myeloma, and Lymphoma.

Understanding how the studies presented in the journal interact with the realities of patient care, such as those experienced by LPNs, provides an interesting perspective. Since LPNs are increasingly required to engage with research as part of their evolving role, it's worth critically analyzing LPN programs that are actively integrating such cutting-edge research into their curriculums.

If you're interested in pursuing this particular career path and wish to engage with research materials such as the Lancet Haematology, the lpn programs in Colorado offer a comprehensive research-based curriculum. Many of these LPN programs are structured to handle the challenges and responsibilities of modern healthcare, ensuring that their graduates can handle a broad range of patient's conditions.

Top Publications

  • Coagulation abnormalities and thrombosis in patients with COVID-19.

    Marcel Levi;Marcel Levi;Jecko Thachil;Toshiaki Iba;Jerrold H Levy

    (2020)
    1494 Citations
  • Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.

    Francesco Passamonti;Chiara Cattaneo;Luca Arcaini;Riccardo Bruna

    (2020)
    541 Citations
  • Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

    Olaf Penack;Monia Marchetti;Tapani Ruutu;Mahmoud Aljurf

    (2020)
    538 Citations
  • Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19.

    Tao Wang;Ruchong Chen;Chunli Liu;Wenhua Liang

    (2020)
    425 Citations
  • Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

    Michele Cavo;Meral Beksac;Lucia Pantani

    (2020)
    347 Citations
  • Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study.

    Akshay Sharma;Neel S. Bhatt;Andrew St Martin;Muhammad Bilal Abid

    (2021)
    336 Citations
  • COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year

    (2021)
    304 Citations
  • Effects of the COVID-19 pandemic on supply and use of blood for transfusion.

    Simon J Stanworth;Simon J Stanworth;Simon J Stanworth;Helen V New;Helen V New;Torunn O Apelseth;Torunn O Apelseth;Susan Brunskill

    (2020)
    295 Citations
  • Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial

    Nagesh Kalakonda;Marie Maerevoet;Federica Cavallo;George Follows

    (2020)
    267 Citations
  • Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

    Heinz Gisslinger;Christoph Klade;Pencho Georgiev;Dorota Krochmalczyk

    (2020)
    259 Citations

Related Online Degrees & Career Pathways

Pursuing a career in medicine often involves exploring various educational routes, especially if you are interested in nursing or specialized advanced practice roles. Many professionals choose to accelerate their qualifications with programs such as a 6-month rn to bsn program online, which offers a fast track to earning a Bachelor of Science in Nursing and expanding career opportunities.

For those already holding an Associate Degree in Nursing, transitioning to advanced roles is possible through tailored programs like adn to np programs. These bridge programs prepare nurses to become nurse practitioners, helping meet the high demand for primary care providers in the healthcare system.

If you are considering a nursing career without prior experience, direct entry msn programs for non nurses online provide an efficient pathway to obtain a Master of Science in Nursing. These programs are designed for career changers and offer clinical training alongside advanced coursework.

When choosing an online nursing school, it is essential to evaluate quality and reputation. Comparisons among top institutions, such as top rated online nursing schools wgu, can help prospective students find programs that best fit their educational goals and learning style.

Best Scientists Contributing to This Journal

Recently Published Articles